PUBLISHER: 360iResearch | PRODUCT CODE: 1500516
PUBLISHER: 360iResearch | PRODUCT CODE: 1500516
[189 Pages Report] The Throat Lozenges Market size was estimated at USD 4.05 billion in 2023 and expected to reach USD 4.24 billion in 2024, at a CAGR 4.91% to reach USD 5.66 billion by 2030.
Throat lozenges are small, medicated tablets designed to dissolve slowly in the mouth, which are commonly used to provide temporary relief for minor sore throat and mouth irritation. These lozenges, which often contain ingredients including menthol, eucalyptus oil, honey, and various herbal extracts, serve key functions, including symptom relief from colds, flu, allergies, increasing saliva production for dry throats, and even possessing antiseptic properties to reduce bacterial presence. The need for throat lozenges has been rising steadily due to multiple factors, which include increased respiratory infections such as colds and flu, exacerbated by growing air pollution and allergens, leading to throat discomfort. Their convenience and easy over-the-counter availability make them a popular choice for quick relief. However, the market faces challenges from alternative remedies, stringent regulations associated with product development and commercialization, possible side effects, and seasonal demand fluctuations. Despite these hurdles, future opportunities abound, including innovative product development to meet the increasing consumer need, expansion into emerging global markets, growth through eCommerce channels, and educational health campaigns promoting throat health.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 4.05 billion |
Estimated Year [2024] | USD 4.24 billion |
Forecast Year [2030] | USD 5.66 billion |
CAGR (%) | 4.91% |
Regional Insights
In the Americas, the throat lozenges market is growing steadily, with the adoption of this tablet owing to the increasing prevalence of respiratory issues, the common cold, and the flu. Moreover, the presence of major pharmaceutical companies in the United States leads to innovations in throat lozenges. Additionally, there is a rising awareness about over-the-counter treatments, which is helping to drive sales of throat lozenges in the region. European countries, in particular, have a high adoption of throat lozenges, especially during the winter months when colds and fevers are more common. Well-established regulatory standards for the development and commercialization of pharmaceutical products in Europe attract manufacturers. In the Middle East and Africa, the throat lozenges market is growing steadily, with increasing urbanization and better healthcare access. Asia-Pacific is experiencing robust growth in the throat lozenges market. This is driven by a large population and a need for effective treatment for high incidence of throat infections and respiratory ailments.
Market Insights
The market dynamics represent an ever-changing landscape of the Throat Lozenges Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Throat Lozenges Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Throat Lozenges Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Sirio Pharma Ventures into Consumer Health Market with Innovative Herbal Gummies
Sirio Pharma expanded its consumer health market footprint following its recent softgel launch by introducing a series of herbal gummies targeting trending health categories. The range includes three vegan, low-to-no sugar gummies intended to address key health concerns, including cough and cold, oral care, and urinary tract infections (UTI). The 'cough and cold' gummy, with its blend of citrus extract, eucalyptus, and acacia honey, aims to enhance the conventional throat lozenges category by providing improved texture and taste. [Published On: 2023-10-06]
Launch of Beekeeper's Naturals Kid's Propolis Throat Soothing Lollipops
Beekeeper's Naturals expanded its range of child-friendly supplements with the introduction of Kid's Propolis Throat Soothing Lollipops following its recent launch at Walmart. Formulated in collaboration with doctors and rigorously tested by third-party labs to ensure they are pesticide-free, these lollipops blend propolis, vitamin D, zinc, wildflower honey, and other clean ingredients to soothe sore throats and bolster immune health. [Published On: 2023-08-22]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Throat Lozenges Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Throat Lozenges Market, highlighting leading vendors and their innovative profiles. These include Bausch Health Companies Inc., Bliss GVS Pharma Ltd, Catalent, Inc., Cipla Limited, Dabur Ltd, Doetsch Grether AG, Ernest Jackson Ltd., Gepach International, GSK PLC, Island Abbey Foods Ltd., J. B. Chemicals & Pharmaceuticals Limited, Mondelez International, Inc., Pfizer Inc., Piramal Group, Prestige Consumer Healthcare Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Ricola AG, Thornton & Ross Ltd, and Traditional Medicinals & WorldPantry.com LLC.
Market Segmentation & Coverage